Possessing a PhD in biochemistry who currently directs company operations and strategy at Neolight, Theracaine, Targazyme and MWS Strategic Advisors, Mark W. Schwartz concurrently serves as an adjunct faculty member in the Masters in Biotechnology program at San Jose State University. Galena Biopharma and Apthera, among other companies, have benefited from Mark W. Schwartz’s biotech-specific business acumen. One of his areas of expertise is mergers and acquisitions (M&A).
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly